ProKidney signs agreement with Jefferies for up to $200 million at-the-market share offering
Bitget2026/10/29 21:33- ProKidney entered an at-the-market sales agreement with Jefferies on October 29, 2026.
- The agreement allows sales of up to $200 million in Class A common stock, subject to the shelf registration statement becoming effective.
- Jefferies will receive up to 3% of gross offering proceeds as compensation.
- The company has no obligation to sell shares and may suspend the offering at any time.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley: AI capital expenditure may reach 10 to 15 trillions USD in the next 10 years
Morgan Stanley stated that capital expenditure in the artificial intelligence (AI) sector could reach $10-15 trillions over the next decade.
Morgan Stanley: Apple's target price lowered to $350
Autoliv completes acquisition of MCF Safety Belts
Refining profits surge and oil prices soar; Saudi Aramco Q3 profits grow by 9% and maintains a dividend of 21.9 billions USD.
Driven by rising refining profits and oil prices, Saudi Aramco's third-quarter profits increased by 9%.
Crypto prices
More
